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Abstract
Preclinical modeling of Parkinson's disease using 6-hydroxydopamine (6-OHDA) has been
valuable in developing and testing therapeutic strategies. Recent efforts have focused on modeling
early stages of disease by infusing 6-OHDA into the striatum. The partial DA depletion that
follows intrastriatal 6-OHDA is more variable than the near complete depletion following medial
forebrain bundle infusion, and behavioral screening assays are not as well characterized in the
partial lesion model. We compared relationships between amphetamine-elicited rotation behavior
and DA depletion following intrastriatal 6-OHDA (12.5 μg) in 6 month vs. 18 month F344/BN
rats, at 2-weeks and 6-weeks post-lesion. We compared the total number of rotations with within-
session (bin-by-bin) parameters of rotation behavior as indicators of DA depletion. Striatal DA
depletion was greater in the young adult than in the middle-aged rats at 2 weeks but not at 6 weeks
post-lesion. The total number of rotations for the whole session and striatal DA depletion did not
differ between the two age groups. Regression analysis revealed a greater relationship between
within-session parameters of rotation behavior and DA depletion in the middle-aged group than in
the young adult group. These results have implications for estimating DA depletion in preclinical
studies using rats of different ages.
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Introduction
Preclinical modeling of Parkinson's disease (PD) using neurotoxins such as 6-
hydroxydopamine (6-OHDA) has been essential to developing and testing potential
therapeutic strategies. The most common protocol involves a unilateral infusion of 6-OHDA
into the medial forebrain bundle in rats. This method produces a near complete dopamine
(DA) depletion in the ipsilateral striatum, a substantial decrease in the number of DA
neurons in the substantia nigra, and severe deficits in contralateral limb use (reviewed by
Deumans et al., 2002). These effects are analogous to those that accompany advanced PD.
Because of the dopaminergic imbalance between the lesioned and the non-lesioned
hemispheres, rats exhibit rotational behavior following the systemic administration of DA
agonists (Hudson et al., 1993; Ungerstedt & Arbuthnott, 1970). The fact that apomorphine-
and amphetamine-elicited rotations are effective behavioral screens for near-complete (i.e.,
>90%) unilateral DA depletions (Hudson et al., 1993) make these assays widely used in
preclinical PD studies.
Due to increased interest in neuroprotective treatment strategies during initial stages of
degeneration, recent efforts have focused on developing sub-maximal but progressive DA
depletions with 6-OHDA in rats (e.g., Barneoud et al., 2000; Deumens et al., 2002; Fleming
et al., 2005; Kirik et al., 1998; Yuan et al., 2005). The goal of these studies is to model early
stages of the disease. One difficulty inherent in such preclinical studies is estimating the
degree of DA depletion prior to post mortem quantification. Although rotation assays
reliably predict advanced striatal DA depletions, their predictive utility in partial lesion
studies is less clear. Several research groups have incorporated sensitive motor assessment
techniques, such as schedule-controlled operant behavior (Lindner et al., 1999), evaluation
of forelimb asymmetry (Fleming et al., 2005), and tests of skilled paw use and postural
adjustments (Barneoud et al., 2000) in their early-stage PD models. Despite the fact that
these tests have great clinical relevance, their implementation can be laborious, sometimes
involve direct investigator involvement, or may be unfeasible for large scale studies. For
these reasons, rotation-based assays remain the most widely-used behavioral screens in
preclinical PD studies. Continued characterization and optimization for studies involving
early-stage models is therefore warranted.
A potential weakness of many preclinical PD studies is the exclusive use of young adult
instead of older animals to model this age-related disease. This is especially relevant to
partial lesion studies, as there are well-documented compensatory processes that accompany
the early stages of idiopathic and experimental PD (Zigmond, 1997), and many of these
compensatory processes may be affected by normal aging (Gould et al., 1996; Stanford et
al., 2001; Yurek & Fletcher-Turner, 2001). While a few studies have addressed this issue by
testing 6-OHDA in older animals (e.g., Cass et al., 2002; Lindner et al., 1999), to our
knowledge there are no published studies comparing conventional measures of drug-elicited
rotation behavior between unilaterally-lesioned young and middle-aged animals. The
purpose of the current study was to characterize the effects of an intrastriatal 6-OHDA
lesion model of early-stage PD in young adult versus middle-aged rats. Our first aim was to
determine the relationship between amphetamine-elicited rotation behavior and the degree
of striatal DA depletion in this partial lesion model. Although apomorphine is also used to
elicit rotations in the unilateral 6-OHDA model, we limited our tests to amphetamine
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because of its greater sensitivity in tests involving partial DA depletions (Hefti et al., 1980;
Hudson et al., 1993). Our second aim was to determine whether the relationship between




Thirty-four F344/BN rats (n=18 six-month-old; n=16 eighteen-month-old; ages are at the
time of lesion) were obtained from NIA colonies. Animals were housed 2 per cage in the
University of Kansas Medical Center's (KUMC's) AAALAC accredited animal facility, and
were maintained on ad libitum food and water, and a 12 hour lights on/off cycle (lights on
from 8:00 am to 8:00 pm). Animals were tested during the light phase of the cycle.
Procedures were approved by the KUMC IACUC and adhered to the Guide for the Care and
Use of Laboratory Animals (National Research Council, 1996).
Unilateral Intrastriatal 6-OHDA Infusion
Animals were anesthetized with sodium pentobarbital (40 mg/kg), and placed in a
stereotaxic frame. A burr hole was placed in the skull over the right striatum (AP + 1.0 mm,
ML + 3.5 mm vs. bregma). A 26 gauge dome tipped needle connected to a microliter syringe
via Teflon tubing was lowered into the striatum (5.0 mm from the dural surface). In the
lesion groups, 12.5 μg 6-OHDA (5.0 μl, at 2.5 μg/μl, in 0.9 % saline with 0.1% ascorbic
acid) was infused at a rate of 0.25 μL/min. The dose of 6-OHDA was based on previous
studies examining the effects of intrastriatal 6-OHDA (Cousins & Salamone, 1996), and the
volume was based on our work examining the effects of intrastriatal delivery of glial cell
line-derived neurotrophic factor on nigrostriatal function (Salvatore et al., 2009; Stanford et
al., 2007). Following an additional 5 min the needle was slowly withdrawn. Bone wax was
applied, the wound was closed with wound clips, and animals were allowed to recover in
their home cages.
Amphetamine-Elicited Rotation
Two weeks after the lesions, all animals were tested for amphetamine-elicited rotation
behavior. Animals were injected with d-amphetamine sulfate (5 mg/kg, s.c.) and placed in a
rotometer for 60 minutes. The rotometer was a 26.5 cm diameter cylinder placed atop a
force-sensing actometer surface (see Fowler et al., 2001). Custom software quantified the
number of ipsiversive rotations (i.e., toward the lesioned side) in untethered animals as a
function of 3-min time bins. On the day following behavioral testing, brains were removed
from the 2-week group for analysis of dopamine content. The 6-week group was kept for
four more weeks so that amphetamine-elicited rotation could be tested again at 6 weeks
post-lesion. Like the 2-week group, their brains were removed on the day following
behavioral testing.
Whole Tissue Levels of DA & DOPAC
On the day following behavioral testing, rats' brains were dissected for fresh tissue harvest.
Brains were placed in a chilled brain mold and 1 mm sections were made allowing free-hand
dissection of bilateral dorsal striatum. Striatal tissue was processed and analyzed for levels
of DA and dihydroxyphenylacetic acid (DOPAC; the primary DA metabolite in rats) as
described previously (Enna et al., 2006). Briefly, levels of DA and DOPAC were quantified
using an isocratic high pressure liquid chromatography system coupled to a dual-channel
electrochemical array detector (ESA Inc., Chelmsford, MA; Model 5100A, E1 + 0.35 mV
and E2 −0.25 mV using a 5011 dual analytical cell).
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We used two methods to quantify relationships between rotation behavior and striatal DA
depletion (expressed as the percentage of DA in the lesioned striatum versus the
contralateral striatum). These data were calculated separately for the young and middle-aged
rats, and all animals were included in analyses regardless of their rotation behavior. First we
calculated correlation coefficients between the total number of rotations per 60-min session
and the percentage of DA depletion across both post-lesion time points. We then examined
rotation behavior in more detail by plotting the number of rotations by 3-min time bins. This
within-session “kinetic” analysis revealed a sigmoidal function, so we used GraphPad Prism
4 (GraphPad Software Inc., San Diego, CA) to fit each animal's rotation data to the
following sigmoidal curve: Y=Bottom+(Top-Bottom)/(1+exp((T50-X)/Slope)), where
Bottom = zero rotations, Top = maximum rotations (so Y = the total number of rotations
during the session), T50 = time bin in which the number of rotations was halfway between
zero and Y, and Slope = steepness of the curve. Within-session rotation behavior fit this
curve well, with a mean R2 across all animals of 0.91 ± 0.04. We conducted the following
exploratory analyses to determine whether these best fit values (T50, Slope, and R2 [how
well each curve fit the function]) were related to DA depletion over and above the
association between DA depletion and the total number of rotations (PASW Statistics
version 18, SPSS, Inc. Chicago, IL). First, zero order Pearson correlation coefficients were
computed for DA depletion by T50, Slope, and R2 for each age group. Second, best fit
variables with significant correlations were entered into a two-step hierarchical multiple
regression model using forced entry of independent variables: Step 1, DA depletion was
regressed on total number of rotations; Step 2, DA depletion was regressed on the
combination of significant best fit variables and the total number of rotations. Third, we
examined the resulting models for overall significance, the change in variance explained by
the second model (ΔR2), standardized regression weights, and partial correlations for
variables in the second model.
Results
A. Dopamine & Total Number of Rotations
Whole tissue levels of DA and DOPAC in the lesioned and contralateral striatum are
presented in Table 1. Dopamine depletion in the lesioned striatum (expressed as % of the
nonlesioned side) was greater in the young group than in the middle-aged group at two
weeks, t(1,14)=4.700, p<0.05, but not at 6 weeks post-lesion (Figure 1a). The total number
of rotations for the whole session, which did not differ significantly between the two age
groups at either time after lesion (Figure 1b), correlated modestly but significantly with the
percentage of DA depletion for both the young (r=0.49, p<0.05) and the middle-aged
(r=0.59, p<0.05) rats.
B. Within-Session Rotation Kinetics
When we examined rotation behavior in more detail by plotting the number of rotations by
3-min time bins, a sigmoidal function was revealed (Figure 2). This function allowed for the
analysis of within-session “kinetic” variables of rotation behavior, including T50 (time bin
in which the number of rotations was halfway between zero and maximum). For older
animals, the association between DA depletion and T50 was significant (r = 0.672, p =
0.003). Otherwise, we did not observe significant correlations between DA depletion and
goodness of fit variables for younger or older animals (p-values > 0.10). As a result, we
conducted hierarchical regression analysis only for older animals, with DA depletion as the
dependent variable and the total number of rotations alone as the independent variable on
step 1 (Model 1), and both total number of rotations and T50 as the independent variables on
step 2 (Model 2). Both models were significant: Model 1 (DA depletion = total number of
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rotations), R2 = 0.352, F(1,14) = 7.068, p = 0.020 and Model 2 (DA depletion = total
number of rotations, T50), R2 = 0.639, F(2,13) = 10.636, p = 0.009. Furthermore, Model 2
accounted for significantly more variance than did Model 1, ΔR2 = 0.287, F(1,12) = 9.554, p
= 0.009. Regression coefficients are positive (Table 2), showing that increasing DA
depletion is associated with increasing number of rotations (β = 0.593) in Model 1 or
increasing number of rotations (β = 0.449) and increasing T50 (β = 0.555) in Model 2. (For
comparison, we repeated this set of analyses for younger animals, but neither R2 nor ΔR2
was significant for the addition of T50, both p-values > 0.10.) Regression coefficients (Table
2b) were used to calculate “predicted DA depletion” from the total number of rotations and
T50 values (Figure 3). Taken together, these results demonstrate that the number of
amphetamine-induced rotations is a significant predictor of 6-OHDA-induced striatal DA
depletion, and that predictive power is further significantly increased when time to complete
50% of the total rotations is considered in middle-aged rats.
Discussion
We report here age-related differences in relationships between unilateral striatal DA
depletion and within-session kinetic characteristics of amphetamine-elicited rotation
behavior in F344/BN rats. The DA depleting effect of intrastriatal 6-OHDA was attenuated
in the middle-aged rats at two weeks post-lesion. DA depletion did not differ between the
two age groups at the 6 weeks time point. The correlation between the number of
amphetamine-elicited rotations and DA depletion was significant for both age groups.
Notably, the addition of T50 to the regression model significantly added to the amount of
variance in DA depletion explained by the total number of rotations alone in older (but not
younger) animals. These results suggest that in studies involving older animals, within-
session analyses of drug-elicited rotation behavior may provide a better indication of percent
DA depletion in a partial lesion model than the total number of rotations.
There is increased interest in developing neuroprotective therapeutic strategies for use in
initial stages of degeneration in PD and other neurodegenerative disorders. The intrastriatal
6-OHDA protocol is considered to be a valid model of early-stage PD (Bjorkland et al.,
1997; Blandini et al., 2007). The fact that within-session kinetic parameters of
amphetamine-elicited rotation behavior were more correlated with the degree of DA
depletion in middle-aged rats in this partial lesion model has significant implications for
preclinical PD research. Although strong rotation behavior can reliably predict advanced DA
depletions (Hudson et al., 1993), estimating partial depletions is a more elusive goal.
Previous studies have demonstrated that rats with partial unilateral DA loss rotate in
response to amphetamine (Hefti et al., 1980; Hudson et al., 1993; Barneoud et al., 2000;
Yuan et al., 2005). However, measures of total rotations or rotation rate were at best able to
differentiate between partial and maximal DA depletions. Although tests of paw reaching
ability provide valuable preclinical measures of bradykinesia and manual dexterity that
correlate with a wider range (40–99%) of DA depletion (Barneoud et al., 1995; Whishaw et
al., 1997), drug-elicited rotation behavior is a more widely-used assay that is easier to
implement. Our results suggest that while the total number of amphetamine-elicited
rotations moderately (but significantly) reflects striatal DA depletion levels in young rats, a
bin-by-bin analysis of rotation behavior greatly enhances the utility of this assay in middle-
aged rats.
It is unclear why within-session rotation parameters correlated greater with DA depletion in
the middle-aged rats than in the young rats. Compensatory processes, such as increased DA
release in residual nigrostriatal terminals (Zigmond et al., 1984) and normalization of
extracellular DA content (Bergstrom & Garris, 2003) have been reported following 6-
OHDA depletion in rats. It is possible that age-related differences in these processes
Bethel-Brown et al. Page 5













(Stanford et al., 2001) altered the relationship between amphetamine-elicited rotation
behavior and DA depletion. The onset of many age-related changes in nigrostriatal function
occurs in middle-age in these animals (e.g., Hebert & Gerhardt, 1998; Yurek et al., 1998), so
it may be that greater variability in this group contributed to this effect. The greater
variability in rotation behavior and DA depletion in the middle-aged rats supports this
hypothesis. Given the increased variability in the middle-aged group, it could be argued that
the greater correlation was more statistical artifact than physiological effect. However, the
difference between the age groups in the regression correlations (R2 = 0.19 vs 0.63) versus
the simple correlations for total number of rotations and DA depletion (R2 = 0.24 vs 0.34)
suggest otherwise.
Age-related changes in the psychomotor stimulating effects of amphetamine may have also
played a role in our findings. In fact, at two weeks post-lesion, within-session onset of
rotations occurred earlier in the younger group, and young rats reached asymptotic rotation
levels within the 60 minute session, while middle-aged rats did not. Because T50 was not a
significant contributor of variance in the regression model for the young adult group, the
greater DA depletion in this group at this time point likely does not underlie this difference.
Previous studies have reported age-related decreases in the number and function of DA
transporters (Hebert et al., 1999) as well as in amphetamine-stimulated DA release (Yurek et
al., 1998). It is therefore possible that amphetamine's effects were greater in young animals.
Our previously-reported findings that amphetamine affects striatal electrophysiological
activity differently in freely-moving aged rats compared to young adult rats (Stanford &
Gerhardt, 2001; Stanford et al., 2002) are consistent with this hypothesis. The fact that
rotation behavior reached asymptote in the young adult within the 60-minute session while it
did not in the middle-aged rats may be related to changes in amphetamine pharmacokinetics
with aging (Truex & Schmidt, 1980).
Our finding regarding the earlier within-session onset of rotations at the 2 week time point
compared to the 6 week time point in the young adult group is conspicuous. One limitation
of our study is that we did not quantify DA in the substantia nigra, where amphetamine
produces much of its locomotor effect (Jackson & Kelly, 1983). It is possible that this
difference may reflect greater nigral involvement in this neurobehavioral relationship.
Retrograde DA depletion produced by intrastriatal 6-OHDA involves early oxidative
damage of DA terminals followed by a cascade of events that culminates in nigral cell death
(Blandini et al., 2007; Sanchez-Iglesias et al., 2007; Sauer & Oertel, 1994). Although
amphetamine-elicited rotation behavior is sensitive to early loss of DA in the striatum,
rotation parameters may be more intimately related to the integrity of the nigrostriatal and
the striatonigral pathways. Previous studies reporting significant relationships between DA
agonist-elicited rotation behavior and nigral DA loss (Hudson et al., 1993; Olds et al., 2006;
Robertson & Robertson, 1989) support this hypothesis. Striatonigral neurons synapse in the
substantia nigra reticulata, forming the so-called “direct pathway” through which the basal
ganglia projects to the motor thalamus and facilitates movement (Bolam et al, 2000). The
substantia nigra reticulata also receives DA input from the substantia nigra compacta and the
nucleus accumbens (reviewed by Hauber, 1998). Amphetamine increases DA activity both
of these nuclei (Jackson & Kelly, 1983; Sharp et al., 1987), and this extrastriatal DA release
may have influenced rotation behavior differently at the earlier time point. Clearly, further
studies are required to determine relationships between motor function, initial striatal DA
loss, and eventual nigrostriatal DA depletion.
Our finding that DA depletion was greater in young rats at two weeks post-lesion than in
middle-aged rats was somewhat unexpected. Previous studies have reported enhanced DA
depletion in older rats following intracerebroventricular or midbrain delivery of 6-OHDA
(Cass et al., 2002; Marshall et al., 1983). Although we did not measure this directly, it is
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possible that age-related decreases in both the number and function of DA transporters
resulted in diminished uptake of 6-OHDA into striatal DA terminals. Significant decreases
in striatal DA transporter binding sites occur in F344 rats beginning at 18 months of age
(Hebert et al., 1999), and the uptake capacity of DA transporter sites is significantly
diminished in F344 rats beginning at 12 months (Hebert and Gerhardt, 1999). This may
explain previous reports that at 12 weeks post-lesion, intrastriatal 6-OHDA resulted in
similar nigral DA cell loss and striatal DA depletion in young versus middle-aged rats
(Lindner et al., 1999). These findings suggest that 6-OHDA infusion site and post-lesion
duration are important factors in preclinical modeling of PD.
Overall, our results indicate that matching animals according to measures that reflect the
within-session onset and bin-by-bin trajectory of amphetamine-elicited rotation behavior
may be a more effective strategy for estimated DA depletion prior to verification following
tissue harvest. This method would be of value when equating drug and vehicle groups prior
to therapeutic intervention in middle-aged animals. Further studies validating this method
using a greater number of rats are warranted to test this hypothesis.
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Striatal dopamine depletion (A) and total number of rotations (B) in young (6 mo) and
middle-aged (18 mo) rats at 2 weeks and 6 weeks post-lesion. Dopamine depletion was
significantly less in middle-aged rats than in young rats at 2 weeks, but not at 6 weeks post-
lesion (*p<0.05). The total number of rotations did not differ between the two age groups at
either post-lesion timepoint.
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Within-session analysis of rotation behavior as a function of each 3 min time bin and weeks
post-lesion in (A) 6-month-old and (B) 18-month-old rats. Values within each bin represent
the cumulative number of rotations at each time point. Although the total number of
rotations was the same between the young and middle-aged rats, young rats exhibited an
earlier and steeper onset of rotations at 2 weeks but not at 6 weeks. Error bars = SEM.
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“Predicted” DA depletion plotted as a function of actual DA depletion for (A) 6-month-old
and (B) 18-month-old rats. Values for predicted DA depletion were derived by using the
coefficients from the regression equations in Table 2B. It is clear that the relationship
between predicted and actual DA depletion is stronger for the middle-aged group than for
the young group.
Bethel-Brown et al. Page 12

























Bethel-Brown et al. Page 13
Table 1
Striatal DA and DOPAC content (ng/g wet weight +/− SEM) as a function of hemisphere (ipsi=lesioned,
contra=non-lesioned), age (6 months vs. 18 months), and time point (2 weeks vs. 6 weeks).
2 weeks 6 weeks
Contra Ipsi Contra Ipsi
6 months n=9 n=8
DA 11 948 ± 825 2119 ± 561 9921 ± 1211 1903 ± 360
DOPAC 5328 ± 1358 1865 ± 566 4840 ± 532 1683 ± 262
18 months n=7 n=8
DA 10 062 ± 2476 3872 ± 1624 12 515 ± 2941 4376 ± 2448
DOPAC 3930 ± 247 2969 ± 880 4831 ± 746 1986 ± 706
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